News

Article

Strategic Interventions Drive Down Therapeutic Discontinuation Rate

Author(s):

Key Takeaways

  • Personalized treatment strategies have advanced lung cancer brain metastases management, integrating targeted therapies and immunotherapies for better outcomes.
  • Stereotactic radiosurgery and whole-brain radiation therapy are evolving with novel systemic therapies, maintaining their importance in treatment.
SHOW MORE

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Related Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.